Endodontic Microsurgery With the Use of L-PRF and an Occlusive Membrane: a Randomized Controlled Clinical Trial
1 other identifier
interventional
56
1 country
1
Brief Summary
This study evaluates the effect of leucocyte and platelet rich fibrin (L-PRF) during endodontic microsurgery (EMS) on patient's post-operative comfort and periapical bone healing. Also the influence of an occlusive membrane barrier in EMS on the periapical bone healing will be studied. The trial design is an open randomized controlled clinical trial with a 2x2 factorial design. Half of the participants will receive EMS with L-PRF (experimental group), the other half without (control group). The control and experimental group will be divided in 2 subsequent groups: half of the participants will receive an occlusive membrane during EMS, the other half not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 14, 2015
CompletedFirst Posted
Study publicly available on registry
August 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedNovember 5, 2020
November 1, 2020
1.3 years
August 14, 2015
November 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient related outcomes
Assessed with a Visual Analog Scale
7 days
Secondary Outcomes (1)
Patient related outcomes
7 days
Other Outcomes (5)
Amount of periapical bone healing in time
4 years
Timeframe in which the cortical bone plate closes
1 year
Bone or scar tissue healing
4 years
- +2 more other outcomes
Study Arms (2)
+ L-PRF
EXPERIMENTALWith leukocyte and platelet rich fibrin
- L-PRF
ACTIVE COMPARATORWithout leukocyte and platelet rich fibrin
Interventions
Eligibility Criteria
You may qualify if:
- Provision of Informed Consent
- Patients in need of an EMS
- EMS is the only option to cure the periapical lesion
You may not qualify if:
- Unlikely to be able to comply with the study procedures, as judged by the investigator
- Orthograde endodontic (re)treatment is indicated
- Known or suspected current malignancy
- History of chemotherapy within 5 years prior to study
- History of radiation in the head and neck region
- History of other metabolic bone diseases
- History of bleeding disorders
- HIV disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, 3000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2015
First Posted
August 19, 2015
Study Start
August 1, 2015
Primary Completion
December 1, 2016
Study Completion
June 1, 2020
Last Updated
November 5, 2020
Record last verified: 2020-11